Literature DB >> 27164996

Development and optimization of ketoconazole oral strips by means of continuous hot-melt extrusion processing.

Mohammed Maniruzzaman1, Smirna Farias2, Ian J Slipper2, Joshua S Boateng2, Babur Z Chowdhry2, Arun Nair3, Dennis Douroumis2.   

Abstract

OBJECTIVES: The aim of this study was to develop mucoadhesive oral strips using hot-melt extrusion as a continuous manufacturing process.
METHODS: Powder blends of ketoconazole, a water-insoluble drug - either hydroxypropyl methylcellulose (HPMC) or soluplus (SOL), sorbitol (SRB) and magnesium aluminometasilicate (MAS) were extruded to manufacture thin strips with 0.5-mm thickness. The presence of the inorganic metasilicate facilitated smooth processing of the extruded strips as it worked as an absorbent directly impacting on the extensive mixing of the drug/excipients inside the extruder barrel. KEY
FINDINGS: The use of MAS also favoured the rapid hydration, swelling and eventual disintegration of the strips. Differential scanning calorimetry and transmission X-ray diffraction analysis revealed the existence of the amorphous drug within the extruded strips. Scanning electron microscopy and energy dispersive X-ray undertaken on the formulations showed a homogeneous drug distribution within the extruded strips.
CONCLUSION: The strips produced via continuous hot-melt extrusion processing showed significantly faster release of ketoconazole compared to the bulk drug substance.
© 2016 Royal Pharmaceutical Society.

Entities:  

Keywords:  Continuous manufacturing; amorphous; energy dispersive X-ray; oral strips; surface analysis

Mesh:

Substances:

Year:  2016        PMID: 27164996     DOI: 10.1111/jphp.12569

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  1 in total

1.  Solubility of Ketoconazole (antifungal drug) in SC-CO2 for binary and ternary systems: measurements and empirical correlations.

Authors:  Gholamhossein Sodeifian; Seyed Ali Sajadian; Fariba Razmimanesh; Seyed Mojtaba Hazaveie
Journal:  Sci Rep       Date:  2021-04-06       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.